What it is used for

This product accepted for registration as 'currently supplied' at the time of commencement of the Act. Variation to Pregnancy Statement in Product Information were approved as specified in the letter of 13 August 1992 from Dr Bijoy Varma. Indicated for the treatment of drug resistant, moderate to severe, hypertension. This drug is not a first line antihypertensive drug and is better used in combination with other therapy such as a sympatholytic agent and a diuretic. INDICATIONS AS AT 28 NOVEMBER 2001 : Hypertension (drug resistant, moderate to severe): as supplementary medication for use together with other antihypertensives such as "beta"-blockers and diuretics; the complementary mechanisms of action of such combined therapy enable the drugs to exert their antihypertensive effects at low doses; in addition, unwanted accompanying effects of the individual substances are either partially offset or even cancelled out.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

• Store below 25 degrees Celsius
• Protect from Light
• Shelf lifetime is 3 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

8 mm cream, flat bevelled edged tablet with a score mark on one side

Images are the copyright of Medicines Information Pty Ltd

We are currently experiencing issues with Medicines Information data. Images displayed may not be current, please refer to the CMI.

Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine. open tool tip to find out more

Pregnant or planning a pregnancy?

For the active ingredient hydralazine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.